SGMO Research and Charts

SGMO - Sangamo Therapeutics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-07-29 (Delayed quote data 2025-05-08)

Last 0.72	Change ⇑ +0.11 (+0.00%)	Volume 3,842,732
	Open 0.66	High 0.75	Low 0.63

8EMA (Daily) 0.71	40EMA (Daily) 0.80	50EMA (Daily) 0.85	STO (Daily) 36.716	MACD Hist (Daily) 0.003
8EMA (Weekly) 0.795	40EMA (Weekly) 1.08	50EMA (Weekly) 1.10	STO (Weekly) 23.188	MACD Hist (Weekly) -0.080


Company Profile
Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.